Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (Ixiaro®)

Daniela Amicizia, Francesca Zangrillo, Piero Luigi Lai, Mariasilvia Iovine, Donatella Panatto

PubMed · 2018 · 38 citations · 31 references

DOIFull text

Open access

Concepts

Abstract

) is a purified, inactivated, whole virus vaccine against JE. It is safe, well tolerated, efficacious and can be administered to children, adults and the elderly. The vaccination schedule involves administering 2 doses four weeks apart. For adults, a rapid schedule (0-7 days) is available, which could greatly enhance the feasibility of its use. Healthcare workers should inform both short- and long-term travelers of the risk of JE in each period of the year and recommend vaccination. Indeed, it has been shown that short-term travelers are also at risk, not only in rural environments, but also in cities and coastal towns, especially in tourist localities where excursions to country areas are organized.

References

31